T. Rowe Price Health Sciences Fund

Class No Load (PRHSX)
Scorecard
5 / 5 Stars
Lipper
5 5 4 5 3
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
B+ (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 1.58 1.58
Stocks 83.75 83.75
Bonds 0.0 0.0
Other 0.68 0.68
Foreign Bonds 0.0 0.0
Foreign Stocks 13.96 13.96
Convertible 0.03 0.03
Preferred 0.0 0.0

Updated 03.31.2014

Top 10 Holdings

Performance as of 06.30.2014

Portfolio as of 03.31.2014

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD 13.57 6.1
Alexion Pharmaceuticals Inc ALXN 22.51 4.63
UnitedHealth Group Inc UNH 9.62 4.3
Biogen Idec Inc BIIB 16.16 3.51
McKesson Corp MCK 17.68 3.24
Aetna Inc AET 20.29 3.11
Valeant Pharmaceuticals International Inc VRX 6.97 2.95
Agilent Technologies Inc A 2.32 2.64
Incyte Corp Ltd INCY 11.77 2.52
Actavis PLC ACT 33.33 2.11